See more : Maptelligent, Inc. (MAPT) Income Statement Analysis – Financial Results
Complete financial analysis of HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HPGC Renmintongtai Pharmaceutical Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- GelStat Corporation (GSAC) Income Statement Analysis – Financial Results
- Zhejiang Fenglong Electric Co., Ltd. (002931.SZ) Income Statement Analysis – Financial Results
- Apeloa Pharmaceutical Co.,Ltd (000739.SZ) Income Statement Analysis – Financial Results
- Hortifrut S.A. (HF.SN) Income Statement Analysis – Financial Results
- Health-Chem Corporation (HCLC) Income Statement Analysis – Financial Results
HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hyrmtt.com.cn
About HPGC Renmintongtai Pharmaceutical Corporation
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.39B | 9.64B | 9.32B | 8.01B | 8.35B | 7.06B | 8.01B | 9.01B | 8.91B | 1.74B | 3.18B | 4.07B | 3.61B | 3.01B | 2.64B | 2.59B | 2.27B | 2.06B | 1.77B | 642.70M | 511.72M | 503.24M | 521.12M | 516.97M | 385.94M | 352.81M | 307.88M | 264.77M | 264.30M | 276.46M | 309.28M | 246.99M | 174.60M | 167.93M |
| Cost of Revenue | 9.39B | 8.72B | 8.32B | 7.09B | 7.33B | 6.15B | 7.08B | 8.10B | 7.92B | 842.11M | 1.88B | 2.01B | 1.82B | 1.51B | 1.34B | 1.23B | 1.17B | 1.09B | 923.41M | 381.66M | 369.41M | 361.56M | 370.42M | 384.08M | 283.35M | 261.67M | 229.10M | 186.70M | 196.50M | 0.00 | 220.45M | 177.78M | 116.22M | 119.69M |
| Gross Profit | 996.42M | 917.54M | 995.13M | 916.82M | 1.02B | 904.13M | 929.31M | 902.50M | 987.90M | 896.69M | 1.30B | 2.06B | 1.79B | 1.49B | 1.30B | 1.37B | 1.10B | 976.75M | 845.59M | 261.04M | 142.31M | 141.68M | 150.70M | 132.89M | 102.59M | 91.15M | 78.78M | 78.07M | 67.81M | 276.46M | 88.83M | 69.21M | 58.39M | 48.24M |
| Gross Profit Ratio | 9.59% | 9.52% | 10.68% | 11.45% | 12.22% | 12.82% | 11.60% | 10.02% | 11.09% | 51.57% | 40.94% | 50.68% | 49.51% | 49.61% | 49.38% | 52.74% | 48.39% | 47.31% | 47.80% | 40.62% | 27.81% | 28.15% | 28.92% | 25.71% | 26.58% | 25.83% | 25.59% | 29.49% | 25.65% | 100.00% | 28.72% | 28.02% | 33.44% | 28.73% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 374.02K | 17.94M | 26.22M | 27.17M | 28.57M | 29.28M | 18.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.99M | 17.50M | 15.33M | 13.77M | 28.42M | 34.14M | 35.05M | 45.34M | 96.88M | 66.17M | 85.00M | 109.36M | 89.31M | 72.38M | 269.83M | 268.27M | 219.49M | 183.99M | 164.96M | 81.89M | 79.82M | 89.67M | 79.69M | 69.40M | 63.55M | 52.52M | 41.28M | 48.11M | 38.04M | 0.00 | 23.40M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 97.98M | 416.73M | 449.05M | 505.74M | 364.01M | 243.99M | 248.11M | 100.68M | 191.74M | 472.86M | 879.48M | 1.20B | 997.75M | 844.85M | 660.51M | 710.32M | 612.44M | 507.74M | 374.18M | 116.61M | 32.97M | 31.03M | 29.53M | 25.39M | 23.68M | 26.57M | 22.60M | 21.71M | 15.97M | 0.00 | 13.13M | 14.35M | 13.57M | 11.34M |
| SG&A | 544.01M | 434.24M | 464.38M | 519.51M | 392.43M | 278.13M | 283.16M | 146.02M | 288.63M | 539.03M | 964.48M | 1.31B | 1.09B | 917.23M | 930.33M | 978.59M | 831.94M | 691.73M | 539.14M | 198.50M | 112.79M | 120.70M | 109.22M | 94.79M | 87.23M | 79.09M | 63.88M | 69.83M | 54.01M | 0.00 | 36.54M | 14.35M | 13.57M | 11.34M |
| Other Expenses | 42.71M | 106.39M | 108.54M | 134.03M | 218.11M | 17.77M | 18.74M | 11.55M | 9.74M | -5.60M | 54.58M | 51.71M | 69.58M | 57.03M | 28.74M | 21.77M | 26.54M | -13.73M | -1.36M | 2.71M | 8.50M | 17.95M | 7.49M | 8.01M | -516.81K | 1.68M | 3.45M | 2.72M | -29.19K | 2.48M | -1.20M | -1.02M | -3.48M | 948.32K |
| Operating Expenses | 597.03M | 540.63M | 572.92M | 653.54M | 610.54M | 549.21M | 569.07M | 547.65M | 681.26M | 757.83M | 1.24B | 1.60B | 1.34B | 1.12B | 954.85M | 1.00B | 851.04M | 710.55M | 557.19M | 205.84M | 118.84M | 126.32M | 114.47M | 100.08M | 91.51M | 82.82M | 66.55M | 71.71M | 57.46M | 2.48M | 49.34M | 41.74M | 36.78M | 32.47M |
| Cost & Expenses | 9.99B | 9.26B | 8.89B | 7.74B | 7.94B | 6.70B | 7.65B | 8.65B | 8.60B | 1.60B | 3.11B | 3.61B | 3.16B | 2.63B | 2.29B | 2.23B | 2.02B | 1.80B | 1.48B | 587.50M | 488.25M | 487.88M | 484.89M | 484.15M | 374.86M | 344.48M | 295.65M | 258.41M | 253.96M | 2.48M | 269.79M | 219.52M | 153.00M | 152.16M |
| Interest Income | 13.92M | 13.34M | 5.94M | 5.75M | 4.15M | 5.25M | 4.46M | 5.03M | 4.75M | 4.97M | 5.30M | 5.73M | 3.57M | 6.20M | -0.96 | 5.66M | 5.04M | 2.83M | 1.08M | 487.85K | 760.71K | 592.96K | 17.59M | 32.10M | -0.71 | -0.39 | -0.69 | -0.48 | -0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 36.34M | 44.42M | 50.32M | 30.75M | 25.28M | 24.45M | 7.19M | 5.16M | 16.28M | 17.75M | 16.57M | 20.33M | 9.30M | 4.17M | 7.56M | 19.18M | 7.91M | 8.58M | 10.10M | 10.45M | 8.15M | 6.79M | 9.34M | 6.93M | 9.01M | 9.23M | 10.89M | 5.68M | 3.06M | 0.00 | 611.91K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 60.18M | 65.89M | 62.74M | 29.92M | 31.10M | 31.26M | 34.06M | 35.37M | 50.68M | 86.55M | 86.62M | 85.01M | 83.33M | 72.95M | 69.87M | 63.81M | 57.33M | 49.77M | 40.60M | 47.48M | 47.04M | 49.16M | 42.60M | 41.05M | 24.70M | 31.88M | 2.10M | -1.35M | -4.58M | 243.13M | -509.47K | -2.73M | -1.56M | -2.05M |
| EBITDA | 480.79M | 442.75M | 469.36M | 275.35M | 413.10M | 382.77M | 382.43M | 344.94M | 296.34M | 225.24M | 128.04M | 571.90M | 581.07M | 499.37M | 417.77M | 437.48M | 370.56M | 310.54M | 303.26M | 95.82M | 79.67M | 76.80M | 105.79M | 118.10M | 35.79M | 34.97M | 12.23M | 6.37M | 10.35M | 276.46M | 39.49M | 27.48M | 21.60M | 15.77M |
| EBITDA Ratio | 4.63% | 4.59% | 5.16% | 3.60% | 5.46% | 5.43% | 4.75% | 4.44% | 4.15% | 12.95% | 6.28% | 14.69% | 16.61% | 17.02% | 16.32% | 17.63% | 16.71% | 15.10% | 17.14% | 14.91% | 15.57% | 15.26% | 20.30% | 22.85% | 9.29% | 11.40% | 3.97% | 2.40% | 3.92% | 100.00% | 12.77% | 11.12% | 12.37% | 9.39% |
| Operating Income | 411.84M | 347.40M | 360.62M | 220.14M | 363.73M | 349.87M | 338.82M | 293.07M | 220.10M | 57.64M | 4.43M | 411.71M | 418.07M | 370.81M | 339.17M | 337.69M | 277.58M | 269.45M | 254.97M | 32.08M | 16.47M | 11.37M | 47.44M | 62.79M | 4.83M | 2.51M | 10.14M | 7.71M | 14.93M | 33.33M | 40.00M | 30.20M | 23.16M | 17.82M |
| Operating Income Ratio | 3.96% | 3.60% | 3.87% | 2.75% | 4.35% | 4.96% | 4.23% | 3.25% | 2.47% | 3.31% | 0.14% | 10.12% | 11.59% | 12.34% | 12.86% | 13.02% | 12.24% | 13.05% | 14.41% | 4.99% | 3.22% | 2.26% | 9.10% | 12.15% | 1.25% | 0.71% | 3.29% | 2.91% | 5.65% | 12.06% | 12.93% | 12.23% | 13.27% | 10.61% |
| Total Other Income/Expenses | -18.46M | -1.85M | -2.02M | -444.95K | -2.46M | -4.15M | 1.05M | -20.33M | 9.29M | -2.18M | 51.86M | 48.81M | 67.45M | 49.28M | 20.18M | -9.92M | 26.43M | -17.25M | -36.89M | -14.21M | 8.01M | 9.48M | 6.41M | 7.33M | -659.46K | -6.83M | -137.56K | 3.55M | -76.87K | 2.48M | -2.32M | -3.74M | -5.03M | -1.10M |
| Income Before Tax | 393.39M | 345.56M | 358.60M | 219.70M | 361.27M | 345.71M | 339.87M | 302.60M | 229.38M | 51.95M | 56.29M | 460.52M | 485.52M | 420.09M | 360.76M | 354.05M | 304.02M | 253.40M | 252.56M | 37.89M | 24.49M | 20.86M | 53.84M | 70.12M | 4.17M | 3.42M | 10.00M | 11.27M | 14.85M | 35.81M | 37.68M | 26.46M | 18.13M | 16.72M |
| Income Before Tax Ratio | 3.79% | 3.58% | 3.85% | 2.74% | 4.32% | 4.90% | 4.24% | 3.36% | 2.57% | 2.99% | 1.77% | 11.32% | 13.47% | 13.98% | 13.67% | 13.65% | 13.40% | 12.27% | 14.28% | 5.90% | 4.78% | 4.14% | 10.33% | 13.56% | 1.08% | 0.97% | 3.25% | 4.26% | 5.62% | 12.95% | 12.18% | 10.71% | 10.38% | 9.96% |
| Income Tax Expense | 101.14M | 82.15M | 82.09M | 74.74M | 93.97M | 87.86M | 85.68M | 78.09M | 96.84M | 25.72M | 64.08M | 107.02M | 97.05M | 80.71M | 67.24M | 73.37M | 32.18M | 38.08M | 52.76M | -2.70M | 6.70M | 10.75M | 9.63M | 8.58M | 1.85M | 2.64M | 1.58M | 1.66M | 2.15M | 4.56M | 5.31M | 5.38M | 5.02M | 7.21M |
| Net Income | 292.16M | 264.48M | 277.30M | 145.26M | 267.33M | 257.86M | 254.20M | 224.51M | 138.92M | 39.85M | 6.46M | 363.97M | 398.60M | 333.82M | 278.79M | 269.28M | 268.09M | 218.25M | 145.13M | 26.69M | 17.79M | 10.11M | 44.21M | 61.54M | 2.32M | 780.86K | 8.42M | 9.61M | 12.70M | 31.25M | 30.41M | 21.08M | 13.11M | 9.51M |
| Net Income Ratio | 2.81% | 2.74% | 2.98% | 1.81% | 3.20% | 3.65% | 3.17% | 2.49% | 1.56% | 2.29% | 0.20% | 8.95% | 11.05% | 11.11% | 10.57% | 10.38% | 11.82% | 10.57% | 8.20% | 4.15% | 3.48% | 2.01% | 8.48% | 11.90% | 0.60% | 0.22% | 2.73% | 3.63% | 4.80% | 11.31% | 9.83% | 8.54% | 7.51% | 5.66% |
| EPS | 0.50 | 0.46 | 0.48 | 0.25 | 0.46 | 0.44 | 0.44 | 0.39 | 0.24 | 0.32 | 0.01 | 0.63 | 0.69 | 0.58 | 0.48 | 0.46 | 0.46 | 0.37 | 0.25 | 0.05 | 0.03 | 0.02 | 0.08 | 0.11 | 0.00 | -0.01 | 0.01 | 0.02 | 0.02 | 0.05 | 0.05 | 0.04 | 0.02 | 0.02 |
| EPS Diluted | 0.50 | 0.46 | 0.48 | 0.25 | 0.46 | 0.44 | 0.44 | 0.39 | 0.24 | 0.32 | 0.01 | 0.63 | 0.69 | 0.58 | 0.48 | 0.46 | 0.46 | 0.37 | 0.25 | 0.05 | 0.03 | 0.02 | 0.08 | 0.11 | 0.00 | -0.01 | 0.01 | 0.02 | 0.02 | 0.05 | 0.05 | 0.04 | 0.02 | 0.02 |
| Weighted Avg Shares Out | 579.92M | 579.89M | 579.89M | 579.89M | 579.89M | 579.85M | 579.83M | 579.83M | 579.78M | 579.86M | 582.17M | 579.85M | 579.86M | 579.85M | 579.92M | 579.85M | 579.85M | 579.94M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M |
| Weighted Avg Shares Out (Dil) | 579.92M | 579.89M | 579.89M | 579.89M | 579.89M | 579.85M | 579.83M | 579.83M | 579.78M | 579.86M | 582.17M | 579.85M | 579.86M | 579.85M | 579.92M | 579.85M | 579.85M | 579.94M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M | 579.85M |
No news found for: 600829.SS
Source: https://incomestatements.info
Category: Stock Reports